Zaleplon

Links shared publicly online about this topic

Somnus Therapeutics Completes Successful Phase 2 Study Of SKP-1041 For Sleep Maintenance Insomnia

medicalnewstoday.com — “Somnus Therapeutics, Inc., a private specialty pharmaceutical company, has completed a Phase 2 dose-ranging study of SKP-1041, a modified-release formulation of zaleplon. The study (SOM201), conduView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on June 2, 2011 at 12:06 pm By:

mnt_sleep MNT Sleep News Health News

Somnus Therapeutics Completes Successful Phase 2 Study Of SKP-1041 For Sleep Maintenance Insomnia http://mnt.to/3WGs #sleep

8 months ago...

Somnus Therapeutics Completes Successful Phase 2 Study Of SKP-1041 For Sleep Maintenance Insomnia

medicalnewstoday.com — “Somnus Therapeutics, Inc., a private specialty pharmaceutical company, has completed a Phase 2 dose-ranging study of SKP-1041, a modified-release formulation of zaleplon. The study (SOM201), conduView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on June 3, 2011 at 5:15 am By:

Sleep_Wisdom Sleep OW OW Health

Somnus Therapeutics Completes Successful Phase 2 Study Of SKP-1041 For Sleep Maintenance Insomnia: Somnus Therap... http://bit.ly/iwWaDa

8 months ago...

Ambien, Sonata, and Lunesta – The Morning After | Brain Blogger

brainblogger.com — “The latest generation of sleep hypnotics -- Ambien (zolpidem), Sonata (zaleplon), and Lunesta (zopiclone) -- have introduced new terms into the AmericanView full resource at brainblogger.com

  • View Related
  • Share

Most Recently Shared on June 11, 2011 at 4:24 pm By:

DrKNDhttp://howtoclickwithpeople.com " /> Dr. Rick Kirschner Personal Development Coach, CAM, and Naturopathic Doctor

Ambien, Sonata, and Lunesta – The Morning After http://zite.to/mPDSyj via @Ziteapp

8 months ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390